D . N I E T H A M M E R + ( I n t r . by E . K l e i h a u e r ) D e p a r t m e n t o f P e d i a t r i c s , U n i v e r s i t y o f U l m , Germany. T r a n s p o r t o f f o l a t e compounds t h r o u g h t h e membrane o f n o r m a l a n d t r a n s p o r td e f i c i e n t l y m p h o i d c e l l s .
The a c t i v e t r a n s p o r t o f f o l i c a c i d (FA) 5-methyltetrahydrofolate (5-MeFH4) a n d m e t h o t r e x a t e ( M T X ) was i n v e s t i g a t e d i n mouse l e u k e m i a L 1 2 1 0 a n d i n a human l y m p h o i d c u l t u r e d c e l l l i n e . I n b o t h c e l l t y p e s e x i s t two d i f f e r e n t t r a n sp o r t s y s t e m s , o n e f o r 5-MeFH4 w h i c h t r a n s p o r t s a l s o M T X a n d o n e f o r FA which i s much l e s s e f f e c t i v e . The f i r s t s y s t e m c a n b e i n h i b i t e d b y b l o c k i n g s u l f h y d r y l g r o u p s i n t h e membrane w i t h o r g a n i c m e r c u r i a l compounds. B u t no S H -g r o u p s seem t o b e i n v o l v e d i n t h e t r a n s p o r t o f FA. I o d o a c e t a t e , h o w e v e r , l e a d s t o a n i n c r e a s e d t o t a l u p t a k e o f M T X . R e s i s t a nc e t o MTX c a n b b d u e t o d e c r e a s e d upt a k e o f t h e f o l a t e a n t a g o n i s t . A c e l l s t r a i n w i t h i m p a i r e d t r a n s p o r t o f M T X t a k e s a l s o u p l e s s 5-MeFH4, w h e r e a s t h e t r a n s p o r t o f FA i s n o t d e c r e a s e d . C o m p e t i t i o n e x p e r i m e n t s show t h a t f o l in i c a c i d s h a r e s t h e t r a n s p o r t s y s t e m w i t h M T X a n d 5-MeFH4. T h i s s y s t e m s e e m s t o b e t h e i m p o r t a n t p a t h w a y f o r t h e upt a k e o f f o l a t e a n d a n t i f o l a t e compounds i n t o t h e s e c e l l s , w h i l e FA i s p r o b a b l y t a k e n u p by a much l e s s s p e c i f i c s y s t e m .
C. LOIRAT, M. BROYER, H8pital des Enfants
M a l d e s , P a r i s , France. Renal t r a n s p l a n t a t i o n i n children. F i r s t year experience.
14 c h i l d r e n , 5 t o 14 years o l d , received cadaveric renb.1 kidneys during 1973. Donors were 2 t o 41 years old. Kidney s i z e was g r e a t e r than normal f o r t h e r e c i p i e n t i n 9 cases, l e s s i n 3 cases, and equivalent i n 2 cases. When t o o large t o be placed i n t h e p e l v i s , t h e kidney was placed i n a paravertebral position. Ureterou r e t e r a l anastomosis was perfornled i n most cases. Treatment was Azatinioprine and corticotherapy. High doses of Furosemide (10 &kg) dur i n g operation prevented ischemic acute r e n a l f a i l u r e , d e s p i t e cold ischemia as long 23 hours. One c h i l d died a f t e r 1 week from i n t r a c e r e b r a l hemorrhage due t o severe hypertension. A second died a f t e r 5 weeks from a d i f f u s e hemorrhagic syndrome. Primary thrombosis of t h e kidney ves s e l s l e d t o transplantectomy i n 1 case. Kidney function i s normal i n 9 cases, chronic reject i o n i s present i n 2. No urologic complications were observed. Hypertension developped i n h a l f of t h e children. One case was associated with r e n a l a r t e r y s t e n o s i s , another with chronic rejection. Hypertension was more frequent i n thos e who had severe hypertension, leading t o binephrectomy, before t r a n s p l a n t a
t i o n . No correlat i o n was found betweenbccurence of hypertens i o n and kidney s i z e . Although follow-up i s t o o s h o r t , growth appears p o s s i b l e i n prepubertal c h i l d r e n , when s t e r o i d doses a r e low. Rehabilit a t i o n was t o t a l within 3 months i n 10 cases.
Cadaveric kidney t y a n s p l a n t a t i o~ seeps t o b e . a valuable t h e r a e u t l c procedure i n children wlth c h r o n~c r e n a l Failure. R.O. ANTTILA*, T.M. BARRATT and J.F. SOOTHILL Department of Immunology, I n s t i t u t e of Child Health, London ' i!ClN lEH, England.
The concentrations of immunoglobulins and complement components i n t h e s e r a of c h i l d r e n with g l o q r u l a r disease.
Various complement components a r e estimated i n the s e r a of p a t i e n t s with r e n a l d i s e a s e f o r t h e purposes of diagnosis and i n v e s t i g a t i o n . Deviation from normality may r e f l e c t involvement i n t h e pathogenetic process, o r may be a secondary consequence of proteinuria. Vi e have t h e r e f o r e s y s t e m a t i c a l l y measured plasma Clq, C4, C3, GBG, 1gG (and s p e c i f i c a l l y subclass 31, 1gA and lgM, and have r e l a t e d them t o t h e plasma concentration of albumin and t o t h e u r i n e a l b u m i d c r e a t i n i n e concentration r a t i o .
GBG c o r r e l a t e s p o s i t i v e l y with t h e plasma albumin concentration, and negatively with t h e u r i n e a l b u m i d c r e a t i n i n e r a t i o , i n d i c a t i n g t h a t i t s serum concentration is a f f e c t e d by u r i n a r y loss. Plasma. I&, but not 1gG s u b c l a s s 3, c o r r e l a t e s p o s i t i v e l y with plasma albumin, i n d i c a t i n g a d i f f e r e n t clearance and/or turnover r a t e of lgG3 from o t h e r 1gG subclasses.
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H.GEIGER*, R.A.GOOD* and N.K.DAY*(Intr. by H.Bicke1). Univ. Children's Hospital. Heidelberg, Germany and Sloan-Kettering Institut, New York, USA.
Complement studies in nephrotoxic serum nephritis (NSN) and aminonucleoside nephrosis (AN) of the rat.
Total complement (CH50) and C1-C9 have been determined in sera and urines of rats with NSN and AN. In NSN, 3 hrs. after injection of antiserum,a significant drop of CH50 and C1-C8 in serum was observed, whereas C9 remained normal. At day 12 CH50 and the complement factors were normal except C1, which was still slightly diminished. In urine, at day 1 only C8 and C9, at day 12 small amounts of CI,C4,C8 and C9 and, less frequently, of C3-C7 could be measured. In AN, at day 12 CH50 and C1-C9 were strikingly diminished in serum. In urine, at day 12 C3,C5,C7,C8 and C9 could be determined regularly, whereas urinary excretion of CI,C4,C2 and C6 was observed in about 50% of the animals. In NSN, the consumption of complement in serum reflects the ongoing immunological process. The low clearances of complement components, compared to AN, may be due to their fixation and inactivation in the kidney. In AN, the reduction of complement in serum may be the result of loss of complement factors in oedema, ascites and urine, and/or of impaired synthesis of these proteins. 901
